All News
The question that changed my life: seven writers on the conundrum that transformed everything
From choosing between a relationship and a baby to imagining a life without sex, how a simple question revolutionised seven livesHannah Booth Continue reading...
Read MoreSTAT+: Denali Therapeutics spinout raises $200M as neuro company resets
Tenvie Therapeutics is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug candidates.
Read MoreSTAT+: Galapagos to split itself into two companies as part of turnaround plan
The beleaguered Belgian firm Galapagos is splitting itself into two companies, with the brandname biotech prioritizing oncology.
Read MoreBudget wishlists calls for more funds, better policies
The deaths of patients in Gujarat, after unnecessary angioplasties post health camps under the Pradhan Mantri Jan Arogya Yojana (PMJAY) scheme, prove that monitoring the efficient use of funds is as
Read MoreDaily glass of milk may cut bowel cancer risk by fifth, research finds
Largest study into diet and disease suggests extra 300mg of calcium a day is associated with a 17% lower riskHaving a large glass of milk every day may cut the risk of bowel cancer by nearly a fifth,
Read MoreMedicaid Expansion Debate Will Affect Other Health Policy Issues Before Montana Legislature
Legislative leaders say the decision whether to renew Montana’s Medicaid expansion program this year will loom over behavioral health spending and hospital regulation, among other topics.
Read MoreIndiana State Senator Moves To Scrap Hospital Monopoly Law He Helped Create
After rival hospitals in Terre Haute scuttled plans to merge, a state senator has introduced a bill to forbid similar mergers by repealing a state law he helped write.
Read MoreSTAT+: Leaving FDA, Califf is unapologetic — and warns of staff departures
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about controversial decision during his term.
Read MoreSTAT+: With a major patent cliff coming, will JPM play host to some serious deal-making?
The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P. Morgan Healthcare Conference.
Read MoreOpinion: How one foundation changed its approach to diversify grant recipient institutions
The Beckman Foundation wanted to make sure it wasn’t unfairly prioritizing elite research institutions. So it tried something new: dual anonymization in peer review.
Read More